Duramox

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Duramox

Property Description
Active Ingredient Amoxicillin
Form Oral preparations (Capsules, Tablets, Suspension)
Pharmacological Class beta-Lactam Antibiotic (Aminopenicillin)
Common Use Treating bacterial infections
Origin Semi-synthetic

What Type of Medicine is Duramox and What is it Made Of?

Duramox is a prescription-only medication whose active ingredient is Amoxicillin, classifying it as a semi-synthetic beta-Lactam antibiotic. This compound is categorized as an essential medicine. Amoxicillin belongs to the Aminopenicillin subclass, which provides it with enhanced chemical stability and the capability for high levels of absorption when taken orally, distinguishing it from older, less readily absorbed penicillins. Duramox is a single-ingredient product, meaning its sole therapeutic component is Amoxicillin, which is clinically recognized for its reliability as a first-line antibacterial agent. This classification is critical because it establishes the drug's purpose as an agent intended solely for fighting bacterial diseases.

Forms of Duramox and Its General Purpose

The active ingredient, Amoxicillin, is designated for oral intake, being available in various dosage forms, including capsules, traditional tablets, and powder for oral suspension. The availability of the suspension form is a key feature, as it allows for flexible administration, ensuring the medication can be taken by patient groups who may require liquid formulations. The fundamental purpose of Duramox is its bactericidal effect; it actively destroys susceptible bacteria to resolve the infection. Amoxicillin works by interfering with the bacteria's ability to construct its protective cell wall. This mechanism allows Duramox to fulfill its primary goal of resolving an active bacterial illness, by eliminating the microbial source.

Regulatory References

  1. World Health Organization Model List of Essential Medicines
  2. Penicillins and Cephalosporins - NCBI Bookshelf

What side effects are possible with Duramox?

Possible Side Effects and Safety Information

Duramox, containing the active substance Amoxicillin, has a safety profile formally documented by government regulatory agencies. The possible adverse effects are officially classified by frequency and the physiological systems affected, in alignment with regulatory standards.

Official Adverse Reaction Classification

Adverse reactions that are categorized as common (occurring in 1% to 10% of patients) typically involve the Gastrointestinal system (e.g., diarrhea and nausea) and the skin (e.g., skin rash). Effects categorized as uncommon include vomiting and urticaria (hives).

Reactions affecting the Blood and Lymphatic System (such as reversible leukopenia) and Hepatobiliary Disorders (e.g., hepatitis and cholestatic jaundice) are classified as very rare, occurring in fewer than 1 in 10,000 patients.

Serious Adverse Reactions and Safety Notes

The regulatory profile highlights rare but clinically significant adverse reactions, including the risk of anaphylaxis and severe cutaneous adverse reactions, such as Stevens-Johnson Syndrome. The potential for Antibiotic-associated Colitis, which may begin during or several weeks after treatment cessation, is also officially documented.

Safety constraints noted in labeling include a contraindication for use in individuals with a history of severe immediate hypersensitivity to any penicillin or other beta-lactam agent. Specific notes for patients with renal impairment indicate the need for dose adjustment due to the potential for increased risk of convulsions and crystalluria. Additionally, patients with infectious mononucleosis are officially warned of an increased likelihood of developing a non-allergic rash upon use.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage with Duramox (Amoxicillin) is associated with several officially documented clinical manifestations and severe physiological outcomes, according to government regulatory sources. The most common immediate manifestations reported are gastrointestinal symptoms, including nausea, vomiting, and diarrhea.

Documented Severe Manifestations

Regulatory documentation highlights the risk of severe outcomes, particularly for the renal system. These include oliguric renal failure resulting from interstitial nephritis, and the formation of amoxicillin crystalluria (crystals in the urine) due to high drug concentration. Central nervous system (CNS) effects, specifically convulsions, have also been reported with high drug levels, a risk heightened in patients with impaired renal function where drug clearance is decreased.

Official Emergency Response

In the event of a suspected overdosage, regulatory guidance mandates that the medication be discontinued immediately. Emergency medical attention must be sought for the management of severe symptoms like oliguric renal failure or convulsions. Overdose management involves providing symptomatic and supportive treatment. Documented procedures include ensuring adequate fluid intake and diuresis to reduce the risk of crystalluria, and the use of hemodialysis to remove Amoxicillin from circulation in severe, life-threatening cases.

Therapeutic Uses of Duramox

What Duramox Treats: Main Uses and Benefits

Duramox is commonly used in clinical settings that involve acute or unstable symptom patterns to address bacterial infections, including those of the ear (acute otitis media), throat (strep throat), lower airways (pneumonia), urinary tract (cystitis), skin (cellulitis), and dental abscesses.

The medication is utilized for infections across these various systems. Its use supports the patient during difficult episodes by easing distress and helps address symptom clusters that may become intense or disruptive, such as fever, localized pain, and tenderness.

The medication is relevant in conditions presenting with systemic or localized discomfort and is applied across domains where additional symptomatic support is needed, such as its use for prophylaxis during high-risk medical procedures where management of symptomatic consequences is appropriate. It may also be part of multi-drug regimens for conditions like H. pylori associated with stomach ulcers.

“The main therapeutic benefit is providing support that helps ease the overall symptom burden during acute episodes.”


Quick Fact: Relief for Infection-Related Pain

Regulatory References

  1. NIH MedlinePlus overview of Amoxicillin

Eligibility and Restrictions for Use

Official Eligibility Rules for Duramox (Amoxicillin)

Official regulatory documents define specific populations that are either permitted, restricted, or absolutely prohibited from using Duramox. This eligibility is determined by patient history, pre-existing conditions, and physiological status.

Classification Population Restriction Eligibility Status
Absolute Contraindication Patients with known serious hypersensitivity to Amoxicillin or other β-lactam antibiotics (e.g., penicillin, cephalosporins) MUST NOT USE
Conditional Avoidance Patients with (or suspected of having) Infectious Mononucleosis MUST BE AVOIDED
Restricted Use Patients with Severe Renal Impairment (CrCl < 30 mL/min) Conditional; requires dose adjustment

Standard use is established for adults and pediatric patients for most labeled infections. However, use in Neonates and Infants (le 3 months) is conditional, often requiring modification due to incompletely developed renal function. For Older Adults (ge 65 years), caution is required, and renal function must be monitored. Amoxicillin is classified as Pregnancy Category B, meaning use is permitted only if clearly needed, and caution must be exercised during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This antibiotic (commonly known as Amoxicillin) has documented interactions with several other medications and substance categories. Before starting treatment, patients should inform their healthcare provider and pharmacist of all current prescription and non-prescription medicines, as well as any vitamins or herbal supplements.

Interacting Product/Class Potential Effect Recommendation/Action
Oral Anticoagulants (e.g., Warfarin) Increased risk of bleeding due to potential changes in gut flora affecting Vitamin K production and INR levels. Increased monitoring of INR and potential dose adjustment of the anticoagulant may be necessary.
Probenecid (Gout medication) Significantly increases and prolongs the concentration of Amoxicillin in the blood. A dose reduction of the antibiotic may be considered if co-administered.
Allopurinol (Gout medication) Increased incidence of skin rash compared to taking the antibiotic alone. Close monitoring for rash development is advised.
Hormonal Contraceptives (Birth Control Pills) May reduce the effectiveness of estrogen-based oral contraceptives. Patients may be advised to use a backup, non-hormonal method of contraception.

Co-administration with other antibacterials like macrolides, tetracyclines, chloramphenicol, or sulfonamides is discouraged in some clinical contexts as these may interfere with the bactericidal activity of Amoxicillin. This antibiotic can also interfere with certain non-enzymatic urine glucose tests, potentially causing a false-positive result for high sugar levels.

Mechanism of Action

How Duramox Works: Mechanism of Action

Duramox (Amoxicillin) acts via a selective mechanism known as selective toxicity, targeting structures present solely within the bacterial organism. The drug's action is fundamentally bactericidal, which involves the active destruction of susceptible bacteria.


Irreversible Inhibition of Cell Wall Assembly

This domain covers the molecular targets and primary interaction type. Duramox acts by irreversibly inhibiting the bacterial Penicillin-Binding Proteins (PBPs), a class of transpeptidase enzymes crucial for the final step of peptidoglycan cross-linking. This mechanism prevents the bacteria from completing a rigid, stable cell wall, a structure critical to bacterial viability.


Induction of Osmotic Cell Lysis

This domain addresses the resulting physiological cascade. The blockade of cell wall synthesis leads to a catastrophic loss of structural integrity, allowing the intense internal fluid pressure (osmotic pressure) of the bacteria to become unopposed. This triggers the rupture of the cell membrane (lysis), resulting in the irreversible loss of viability of the susceptible pathogenic organism.

Dosage and Administration Information

How to Use Duramox (Amoxicillin) — Administration Guidelines

Duramox (Amoxicillin) must be used strictly according to the procedures and instructions outlined in professional medical guidelines and prescribing information.


Administration and Dosage

Administration Scope Instruction
Route of Administration Oral (Capsules, Tablets, Suspension) or Parenteral (Intravenous/Intramuscular)
Standard Dosing Typically 250 mg to 875 mg per dose for adults, depending on severity. Pediatric dosing is based on weight (mg/kg).
Frequency Twice daily (q12h) or three times daily (q8h).
Timing in Relation to Meals Can generally be taken without regard to meals; however, specific forms like the 875 mg tablet are studied for administration at the start of a light meal.

Preparation and Procedural Rules

  • Oral Suspension Preparation: Powder must be reconstituted by adding the specified volume of water and shaking well before the first use. The suspension must be shaken again before each subsequent dose measurement. A calibrated measuring device must be used to ensure accurate dosing.
  • Tablet/Capsule Intake: Most tablets and capsules must be swallowed whole. Chewable tablets must be chewed thoroughly before swallowing.
  • Course Completion: Treatment duration is specified for each indication (e.g., typically 10 days for S. pyogenes infections) and must be completed, even if symptoms resolve earlier.

Population-Specific Rules

  • Renal Impairment: Dosing requires adjustment for patients with significant renal dysfunction (Glomerular Filtration Rate < 30 mL/min), often limiting the frequency and maximum daily dose.
  • Infants (≤ 3 months): Maximum daily dose is limited to 30 mg/kg/day divided every 12 hours.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Duramox (Amoxicillin)


Evidence for Use in Acute Ear and Throat Infections (Otitis Media and Pharyngitis)

Research examining the use of Duramox for Acute Otitis Media (ear infection) has been conducted extensively using short-term Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews. The research primarily focused on pediatric patients and measured outcomes related to the rate of clinical resolution and bacteriological clearance. For Streptococcal Pharyngitis (Strep throat), research primarily examined outcomes related to bacteriological eradication and the prevention of subsequent, specific complications. While clearance patterns are consistently reported, the evidence base acknowledges concerns regarding increasing bacterial resistance and notes limited insight into the comparative effect on overall symptom duration in some cases.


Evidence for Use in Respiratory and Systemic Infections (Pneumonia and Sinusitis)

For Lower Respiratory Tract Infections (LRTI), including non-severe Community-Acquired Pneumonia (CAP), research utilized RCTs and large observational studies. Regulatory documentation describes research patterns for the use of Duramox in non-severe CAP. However, research exploring its use for uncomplicated LRTI sometimes reported that findings were mixed regarding symptom recovery duration when compared to non-antibiotic comparison groups. For Acute Bacterial Sinusitis, studies monitored symptom resolution, but findings regarding the overall duration of illness were also reported as mixed compared to non-treatment comparison groups.


Evidence in Special Populations and Research Gaps

The body of research includes studies observing the use of Duramox across different age groups, including pediatric groups and older adults. However, research highlights that data for certain groups remain insufficient, particularly for patients with severe, complex underlying health issues. Findings describe group patterns, but research does not provide individual predictions regarding whether an individual with complex medical needs will respond similarly to the general population studied. Because the conditions studied are typically acute, long-term effects are not fully established or consistently tracked across the evidence base, and limited information exists regarding durability of observed findings beyond short-term follow-up periods.

Key Studies & References Amoxicillin (Oral Route) - Drug Information

Frequently Asked Questions (FAQ)

Common questions about Duramox (FAQ)

Q: What is the main reason doctors prescribe Duramox?

A: According to official regulatory documents, Duramox is prescribed to treat various types of bacterial infections caused by susceptible organisms. These infections include certain issues affecting the ear, nose, throat, skin, and lower respiratory tract.

Q: Is Duramox available over the counter, or does it require a prescription?

A: Duramox is defined in regulatory contexts as a Prescription Only Medicine (POM). This classification indicates that the medicine is only available with a valid prescription from a qualified healthcare provider.

Q: Are there different brand names for the medicine Duramox?

A: Duramox is a proprietary (brand) name. The active ingredient is Amoxicillin, which is its generic name. This generic ingredient may be available under several other brand names globally.

Q: What kind of infections is Duramox typically used to treat?

A: Official product information indicates Duramox is used for a range of bacterial conditions. These include infections like acute otitis media (ear infections), specific skin infections, and certain infections of the respiratory and genitourinary tracts.

Q: How quickly does Duramox generally start to have an effect?

A: Official pharmacokinetic data shows that the concentration of the drug reaches its maximum level in the bloodstream typically within one to two hours after an oral dose. While the drug is active quickly, the timeframe for a patient to feel symptom relief can vary.

Q: Is it normal to feel tired after starting Duramox?

A: Yes, tiredness is listed in official documents as a possible general side effect. This may be described as fatigue or malaise (a general feeling of discomfort) in the official product information.

Q: Can Duramox cause changes in sleep patterns?

A: Regulatory documents list central nervous system effects as potential undesirable effects. These can include insomnia (difficulty sleeping) and agitation.

Q: Does Duramox interact with common pain relievers like ibuprofen?

A: Official drug interaction lists do not typically specify an interaction between Duramox and nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen. Patients are generally advised to inform their healthcare provider of all other medicines they are taking.

Q: What happens if a dose of Duramox is missed?

A: Patient instructions described in official literature often state that a missed dose may be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped entirely.

Q: Can older adults (seniors) use Duramox?

A: Yes, Duramox can be used by older adults. However, official guidance in the geriatric use section notes that kidney function may be reduced in older patients. For this reason, official guidance notes that dose adjustment may be necessary.

Q: Is Duramox safe for children to use?

A: Duramox is approved for use in the pediatric population, and there are specific guidelines for its use in infants and children. Dosing is based on the child's weight and the specific bacterial infection being treated.

Q: What are the most common side effects listed for Duramox?

A: According to official product information, the most common undesirable effects reported include gastrointestinal issues. These most frequently consist of diarrhea, nausea, and skin rash.

Q: Does the evidence show that Duramox is used for long-term conditions?

A: Duramox is an antibiotic and is indicated for acute bacterial infections, which typically require a short, defined treatment course. For patients who may need to take the medicine for longer than 14 days, official documents advise periodic monitoring of organ system functions.

Q: What should a patient look out for that indicates a serious reaction to Duramox?

A: Official regulatory warnings include signs of severe hypersensitivity reactions. Patients should look out for symptoms like difficulty breathing, swelling of the face, or severe diarrhea, which official documents describe as situations that require immediate medical attention.

Q: Why is Duramox sometimes prescribed for different medical problems?

A: The drug is prescribed for a variety of conditions because the specific types of susceptible bacteria it targets can cause infections in many areas. This includes the ears, throat, lungs, and skin, leading to different medical problems.

Q: Is it possible to be allergic to Duramox?

A: Yes. Official documents state that Duramox is contraindicated (should not be used) in patients with a known history of serious hypersensitivity reactions. This includes allergies to Duramox or other penicillin-class drugs.

Q: Does Duramox affect energy levels?

A: Effects on energy levels are indirectly described in official documents via listed undesirable effects. These can include general feelings of fatigue or malaise.

Q: Can Duramox be used by people who have liver problems?

A: Use in patients with severe hepatic (liver) impairment is addressed in official product information. While it may be used, warnings advise that close monitoring of liver enzyme levels is often recommended.

Q: How long does Duramox stay in the body after the treatment is finished?

A: Official pharmacokinetic data indicates that Duramox has a relatively short half-life. This means the medicine is quickly eliminated from the body, with the primary route of elimination being through the kidneys.

Q: Why do some people need to take Duramox for several days?

A: Official guidance emphasizes that the full prescribed course must be completed. This is crucial to ensure the complete eradication of the bacterial infection and to help prevent the development of drug-resistant bacteria.

Q: Can Duramox be taken if a person has a history of stomach ulcers?

A: Stomach ulcers are not listed as a contraindication in regulatory documents. However, the medicine may cause general gastrointestinal disturbances, such as nausea and diarrhea, as listed in the undesirable effects.

Q: Does taking Duramox cause light sensitivity?

A: Photosensitivity (light sensitivity) is not commonly documented in official sources. However, skin rashes are listed as a frequently observed undesirable effect, which may sometimes be triggered by sun exposure.

Q: What does the research say about Duramox use during pregnancy?

A: Regulatory documents classify the use of Duramox in pregnancy, noting that limited clinical data is available. The drug may be considered for use if the potential benefit is judged to outweigh the potential risks, as determined by a healthcare provider.

Q: Can women who are breastfeeding use Duramox?

A: Official information indicates that the active ingredient may pass into breast milk in small amounts. Regulatory documents advise caution due to potential risks to the infant, such as sensitization or minor disturbance of the gut flora.

Q: Is Duramox considered a 'strong' or 'broad-spectrum' medicine?

A: Duramox is chemically defined in regulatory sources as a semi-synthetic, broad-spectrum antibiotic. This classification means it is effective against a wide range of bacteria, including both Gram-positive and Gram-negative types.

Q: Are there specific instructions for what to do if a skin rash develops while on Duramox?

A: Regulatory warnings indicate that the medicine should be discontinued immediately if a severe hypersensitivity reaction, such as a serious skin rash, is suspected, and that prompt medical attention is required.

Q: Is it common for people to get yeast infections after using Duramox?

A: Candidiasis (a fungal or yeast infection) of the skin and mucous membranes is listed in official documents as a common undesirable effect of Duramox. This occurs due to the change in the body's normal microbial balance.

Q: Can Duramox be taken with high-blood pressure medications?

A: Official drug interaction lists do not typically identify a direct, specific interaction between Duramox and the common classes of medications used to treat high blood pressure (antihypertensives).

Q: Are there any warnings about operating machinery while using Duramox?

A: Official product information states that Duramox may cause undesirable effects such as dizziness or convulsions (seizures). Regulatory guidance advises that caution should be exercised if these effects occur, as they have the potential to affect the ability to drive or operate machinery.

Q: What information is available about Duramox and alcohol consumption?

A: The official drug label does not specifically list alcohol as a documented interaction with Duramox. This indicates that no specific adverse interaction between the medicine and alcohol is officially noted.

Q: Do regulators mention any specific tests needed before starting Duramox?

A: For standard, short courses of Duramox, no specific baseline tests are usually mentioned. However, official guidance may advise periodic assessment of organ system functions, including kidney and liver function, during prolonged treatment.

Q: Is it possible to become resistant to the effects of Duramox over time?

A: Yes, the potential for the development of drug-resistant bacteria is a major concern noted in official warnings. For this reason, the medicine is only indicated for infections proven or strongly suspected to be caused by susceptible bacteria.

Q: How is the long-term safety of Duramox described in regulatory reports?

A: Duramox is indicated for acute infectious diseases, not long-term conditions. Official documents state that if treatment extends beyond 14 days, periodic assessments of organ system function (such as kidney and liver) are advised.

Q: Can Duramox cause mood changes or anxiety?

A: Official product information lists psychological effects as potential undesirable effects. These can include documented changes such as anxiety, agitation, and confusion.

Q: Is Duramox used only for short-term illnesses?

A: Official indications for Duramox are focused on the treatment of acute bacterial infections. These are generally classified as short-term illnesses that require a limited and defined course of treatment.

Q: Does the drug label describe any situations where Duramox should be immediately stopped?

A: Yes. The label warns that Duramox should be stopped immediately if a patient experiences signs of a severe allergic reaction (anaphylaxis) or a potentially fatal skin reaction, which official documents state requires emergency medical care.

How should Duramox be stored and disposed of?

How to Store and Dispose of Duramox?

The official storage and disposal requirements for Duramox are established to maintain the drug’s quality and prevent accidental exposure.


Labeled Storage Conditions

Requirement Classification
Temperature Store at controlled room temperature (20 C to 25 C).
Protection Keep in the original container, tightly closed, to protect from moisture.
Handling Keep out of the reach of children, in compliance with the Poison Prevention Packaging Act (PPPA).

️ Disposal Instructions

Official labeling instructs users to follow any specific disposal information provided with the medication. If no specific instructions or authorized drug take-back program are readily available, the medication must be mixed with an unappealing substance, such as dirt or used coffee grounds, and then sealed in a container before disposal in the household trash. This method is used to discourage unintentional ingestion by people or pets.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Duramox found in:

A-Z Index: